Tube Pharmaceuticals to Develop a New Class of Anti-cancer Drugs
Seed financing completed
25-Jul-2011 -
Ascenion, the technology transfer partner of the Helmholtz Centre for Infection Research (HZI), and Austria Wirtschaftsservice (aws) announced the foundation of Tube Pharmaceuticals, a Vienna-based biopharmaceutical company dedicated to the development of tubulysins as powerful anti-cancer drugs. ...
Ascenion
biopharmaceuticals
cancer
+3